Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Arthritis and Rheumatism|September 8, 2011
Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritisMelissa Mavers, Carla M Cuda, Alexander V Misharin, et al.
Cell Reports|April 30, 2025
Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissuesReyka G Jayasinghe, Derek Hollingsworth, Nathan C Schedler, et al.
Blood|October 21, 2016
DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host diseaseHidekazu Nishikii, Byung-Su Kim, Yasuhisa Yokoyama, et al.
European Journal of Immunology|February 4, 2009
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophagesJohn C Scatizzi, Melissa Mavers, Jack Hutcheson, et al.
Transplantation and Cellular Therapy|November 22, 2025
Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of ImmunityThomas Pfeiffer, Lisa Murray, Feng Gao, et al.
Arthritis and Rheumatism|January 30, 2010
Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosisJohn C Scatizzi, Jack Hutcheson, Richard M Pope, et al.
Research Square|October 3, 2025
CD1d+ Goblet Cells Expand Colon-Resident Immature, Intermediate and Differentiated iNKT Cells to Limit ColitisVini John, Bibiana Barrios, Jacqueline D Wang, et al.
The Journal of Clinical Investigation|April 15, 2021
Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation toleranceToshihito Hirai, Teresa L Ramos, Po-Yu Lin, et al.
Blood|May 26, 2021
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effectsKristina Maas-Bauer, Juliane K Lohmeyer, Toshihito Hirai, et al.
Science Translational Medicine|December 20, 2023
Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutationsŠimon Borna, Esmond Lee, Jason Nideffer, et al.
Pageof 3